Uncategorized
Masket IOL negates dysphotopsia
SAN DIEGO — No patients reported negative dysphotopsia after implantation of the Morcher 90S IOL, the production model of an anti-dysphotopic IOL, according to the technology’s patent holder, Samuel Masket, MD.Masket reported initial clinical results of implantation of the anti-dysphotopsia IOL in 38 cases at the American Society of Cataract and Refractive Surgery meeting. Follow-up to date is between 1 and 18 months.